Binex Co., Ltd.

053030 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩6,570.00
+0.77%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Moderate debt: debt-to-equity of 0.66.
  • Current assets comfortably cover current liabilities (current ratio 1.8).

!Watch-points

  • Thin interest cover: operating profit covers interest only about -1 times.
  • Return on equity is on the lower side at -1.7%.
  • Return on capital employed is on the lower side at -1.8%.
  • The company reported a net loss in the latest period.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
0.79

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
3 / 4

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 4 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩2,092억
Current Price₩ 6,570.00
High / Low₩ 18,860.00 / 5,500.00
Stock P/E-65.05
Book Value₩ 5,881.00
ROCE-1.82%
ROE-1.72%
Debt to Equity0.66
Current Ratio1.80
EPS₩ -101.00
PAT Margin-1.95%
ICR-1.00
Compounded Sales Growth
10 Years
5 Years 5.06%
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year -1.72%
Educational data only. Not a recommendation to buy, sell or hold any security.